Pedram Argani

9.8k total citations · 1 hit paper
54 papers, 5.1k citations indexed

About

Pedram Argani is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Pedram Argani has authored 54 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 23 papers in Oncology and 17 papers in Cancer Research. Recurrent topics in Pedram Argani's work include Epigenetics and DNA Methylation (20 papers), Cancer-related gene regulation (14 papers) and Cancer Genomics and Diagnostics (9 papers). Pedram Argani is often cited by papers focused on Epigenetics and DNA Methylation (20 papers), Cancer-related gene regulation (14 papers) and Cancer Genomics and Diagnostics (9 papers). Pedram Argani collaborates with scholars based in United States, United Kingdom and Italy. Pedram Argani's co-authors include Saraswati Sukumar, Mary Jo Fackler, Christine A. Iacobuzio–Donahue, Robb E. Wilentz, Jyoti Mehrotra, Kornélia Polyák, Angelo M. De Marzo, Elizabeth Garrett, Charles J. Yeo and Ralph H. Hruban and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Pedram Argani

52 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The PIK3CA gene is mutated with high frequency in human breast cancers

2004 519 citations Pedram Argani, Hiroyuki Konishi et al. Cancer Biology & Therapy profile →

Peers

Pedram Argani

ONCOL

PRM

GENET

Paul Haluska United States

Libero Santarpia Italy

Charles Lu United States

Félix Bonilla Spain

Daniel Rosen United States

Amir A. Jazaeri United States

Β. Michael Ghadimi Germany

Joshua F. McMichael United States

Lu‐Zhe Sun United States

ST Cheung Hong Kong

Paul Haluska United States

Pedram Argani

2.5k ×0.7

2.0k ×1.0

ONCOL

1.1k ×0.8

618 ×1.1

PRM

667 ×1.2

GENET

Citations per year, relative to Pedram Argani Pedram Argani (= 1×) peers Paul Haluska

Countries citing papers authored by Pedram Argani

Since Specialization

Citations

This map shows the geographic impact of Pedram Argani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedram Argani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedram Argani more than expected).

Fields of papers citing papers by Pedram Argani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedram Argani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedram Argani. The network helps show where Pedram Argani may publish in the future.

Co-authorship network of co-authors of Pedram Argani

This figure shows the co-authorship network connecting the top 25 collaborators of Pedram Argani. A scholar is included among the top collaborators of Pedram Argani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedram Argani. Pedram Argani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cimino‐Mathews, Ashley, Angelo M. De Marzo, Jessica Hicks, et al.. (2017). Mutational profiles of breast cancer metastases from a rapid autopsy series reveal multiple evolutionary trajectories. JCI Insight. 2(24). 18 indexed citations

Almendro, Vanessa, Hee Jung Kim, Yu-Kang Cheng, et al.. (2014). Genetic and Phenotypic Diversity in Breast Tumor Metastases. Cancer Research. 74(5). 1338–1348. 129 indexed citations

Han, Liangfeng, Adam Diehl, Nguyen K. Nguyen, et al.. (2014). The Notch Pathway Inhibits TGFβ Signaling in Breast Cancer through HEYL-Mediated Crosstalk. Cancer Research. 74(22). 6509–6518. 27 indexed citations

Fackler, Mary Jo, Zoila A. Lopez‐Bujanda, Christopher B. Umbricht, et al.. (2014). Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast Cancer. Cancer Research. 74(8). 2160–2170. 118 indexed citations

Moore, Heather M., Maria E. González, Kathy A. Toy, et al.. (2013). EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis. Breast Cancer Research and Treatment. 138(3). 741–752. 41 indexed citations

Gao, Dingcheng, Natasha Joshi, Hyejin Choi, et al.. (2012). Myeloid Progenitor Cells in the Premetastatic Lung Promote Metastases by Inducing Mesenchymal to Epithelial Transition. Cancer Research. 72(6). 1384–1394. 234 indexed citations

Fackler, Mary Jo, Christopher B. Umbricht, Danielle Williams, et al.. (2011). Genome-wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence. Cancer Research. 71(19). 6195–6207. 159 indexed citations

Singhi, Aatur D., Ashley Cimino‐Mathews, Robert B. Jenkins, et al.. (2011). MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors. Modern Pathology. 25(3). 378–387. 62 indexed citations

Lo, Pang-Kuo, Ji Shin Lee, Xiaohui Liang, et al.. (2010). Epigenetic Inactivation of the Potential Tumor Suppressor Gene FOXF1 in Breast Cancer. Cancer Research. 70(14). 6047–6058. 67 indexed citations

10.

Ostrow, Kimberly Laskie, Hannah Lui Park, Mohammad Obaidul Hoque, et al.. (2009). Pharmacologic Unmasking of Epigenetically Silenced Genes in Breast Cancer. Clinical Cancer Research. 15(4). 1184–1191. 59 indexed citations

11.

Axilbund, Jennifer E., Pedram Argani, Mihoko Kamiyama, et al.. (2009). Absence of germline BRCA1 mutations in familial pancreatic cancer patients. Cancer Biology & Therapy. 8(2). 131–135. 42 indexed citations

12.

Lo, Pang‐Kuo, Wei Wen Teo, Xiaohui Liang, et al.. (2009). MethySYBR, a Novel Quantitative PCR Assay for the Dual Analysis of DNA Methylation and CpG Methylation Density. Journal of Molecular Diagnostics. 11(5). 400–414. 32 indexed citations

13.

Wu, Julie M., Mary Jo Fackler, Marc K. Halushka, et al.. (2008). Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases. Clinical Cancer Research. 14(7). 1938–1946. 165 indexed citations

14.

Cornblatt, Brian, Lingxiang Ye, Albena T. Dinkova‐Kostova, et al.. (2007). Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. Carcinogenesis. 28(7). 1485–1490. 253 indexed citations

15.

Lee, Ji Shin, Pang‐Kuo Lo, Mary Jo Fackler, et al.. (2007). A comparative study of korean with caucasian breast cancer reveals frequency of methylation in multiple genes correlates with breast cancer in young, ER, PR-negative breast cancer in korean women. Cancer Biology & Therapy. 6(7). 1114–1120. 25 indexed citations

16.

Agoston, Agoston T., Pedram Argani, Angelo M. De Marzo, Jessica Hicks, & William G. Nelson. (2007). Retinoblastoma Pathway Dysregulation Causes DNA Methyltransferase 1 Overexpression in Cancer via MAD2-Mediated Inhibition of the Anaphase-Promoting Complex. American Journal Of Pathology. 170(5). 1585–1593. 11 indexed citations

17.

Gallicchio, Lisa, Sonja I. Berndt, Craig J. Newschaffer, et al.. (2006). Polymorphisms in estrogen-metabolizing and estrogen receptor genes and the risk of developing breast cancer among a cohort of women with benign breast disease. BMC Cancer. 6(1). 173–173. 40 indexed citations

18.

Karakas, Bedri, Ashani T. Weeraratna, Abde M. Abukhdeir, et al.. (2006). Interleukin-1 alpha mediates the growth proliferative effects of transforming growth factor-beta in p21 null MCF-10A human mammary epithelial cells. Oncogene. 25(40). 5561–5569. 22 indexed citations

19.

Rosty, Christophe, Takashi Ueki, Pedram Argani, et al.. (2002). Overexpression of S100A4 in Pancreatic Ductal Adenocarcinomas Is Associated with Poor Differentiation and DNA Hypomethylation. American Journal Of Pathology. 160(1). 45–50. 181 indexed citations

20.

Argani, Pedram, Frederic B. Askin, Paul M. Colombani, & Elizabeth J. Perlman. (2000). Occult Pulmonary Synovial Sarcoma Confirmed by Molecular Techniques. Pediatric and Developmental Pathology. 3(1). 87–90. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact